XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Dec. 31, 2023
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY  
Schedule of Reconciliation of Numerator And Denominator of Basic and Diluted Earnings (Loss) Per Share
A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):
 
For the three months endedFor the nine months ended
December 31,December 31,
2023202220232022
Basic earnings (loss) per share:
Net earnings (loss) from continuing operations$13,379 $(30,520)$16,269 $(88,174)
Earnings from discontinued operations, net of tax598 836 985 836 
Net earnings (loss)$13,977 $(29,684)$17,254 $(87,338)
Basic weighted-average shares outstanding65,961 64,784 66,247 66,761 
Continuing operations$0.20 $(0.47)$0.25 $(1.32)
Discontinued operations0.01 0.01 0.01 0.01 
Basic earnings (loss) per share$0.21 $(0.46)$0.26 $(1.31)
Diluted earnings (loss) per share:
Basic weighted-average shares outstanding65,961 64,784 66,247 66,761 
Dilutive effect of common stock options and restricted stock units as computed under the treasury stock method (1)1,982 — 1,486 — 
Diluted weighted-average shares outstanding67,943 64,784 67,733 66,761 
Continuing operations$0.20 $(0.47)$0.24 $(1.32)
Discontinued operations0.01 0.01 0.01 0.01 
Diluted earnings (loss) per share$0.21 $(0.46)$0.25 $(1.31)

(1) The number of common stock options and restricted stock units as computed under the treasury stock method that would have otherwise been dilutive but are excluded from the table above because their effect would have been anti-dilutive due to the net loss position of the Company was 0.5 million and 0.6 million in the three and nine months ended December 31, 2022.
Schedule of Anti-dilutive Options, Warrants and Restricted Stock Units Excluded from Computation of Loss Per Share
Restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted loss per share because their effect would have been anti-dilutive (other than due to the net loss position of the Company) are shown below (shares in thousands):
 
For the three months endedFor the nine months ended
December 31,December 31,
2023202220232022
Number of shares underlying restricted stock units1,046 6,215 1,065 2,980